D-0073-2027 Class II Ongoing

Recalled by The Ritedose Corporation — Columbia, SC

FDA drug recall D-0073-2027 was initiated by The Ritedose Corporation on Oct 15, 2026 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specification The recall status is ongoing. Affected quantity: 3210 Cartons.

Recall details

Product Type
Drugs
Report Date
Nov 4, 2026
Initiation Date
Oct 15, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3210 Cartons

Product description

Formoterol Fumarate Inhalation Solution, 20mcg/2mL, packaged in cartons of 30 individually wrapped vials (NDC 76204-030-01) and 60 individually wrapped vials (NDC 76204-030-02), Rx only, Manufactured for and by: Ritedose Pharmaceuticals, LLC, Columbia, SC

Reason for recall

Failed Impurities/Degradation Specification

Distribution pattern

Nationwide within the U.S

Code information

Lot: 25BL0, Expires: 02/28/2027

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0073-2027
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0073-2027. Report a data issue: hello@regdatalab.com.